has been advised,9 while more recent recommenda-
Night waking is one of the most common behavioural problems in young children. Estimates point during the first 18 months. '4 There have been a few studies on the efficacy of night time sedation in toddlers. One community survey reported that only 11% of parents whose children received hypnotics thought the medication had helped, but methodological problems in this study included the use of different drugs, unspecified dosages, and uncertain compliance.'5 A controlled study of diphenhydramine in children aged 2 to 12 years with various sleep problems showed treatment with the drug to be more effective than treatment with placebo, but the study did not examine differences due to children's age or the type of sleep problem. ' The study was a randomised, double blind crossover evaluation of trimeprazine tartrate given in a dose of 6 mg/kg (45-90 mg). A two week baseline period after the initial acceptance was followed by four weeks on either drug or placebo then a one week washout period followed by the other medication. All children were followed up one month after completion of the trial, when a semi-structured, standardised interview was carried out with the mothers to elicit childhood behaviour problems and parental psychiatric history.
Sleep was assessed by means of parental sleep diaries, which were kept throughout the trial. These recorded the time of going to bed, going to sleep, and morning waking and time and duration of night time wakings and of daytime naps. Parents also completed weekly symptom checklists while their child was on treatment with drug or placebo and an overall treatment questionnaire at the end of each course. The study had received approval from the local ethics committee for research with human subjects.
Statistics. All analyses employed paired, two tailed t tests using the method described by Armitage for ascertaining period effects and treatment x period interactions in crossover trials.'8
Results
Characteristics of the children. A total of 59 referrals were received, of whom 20 entered and 18 completed the study. Two children dropped out during the first treatment course, one because the mother thought the medication was giving her child nightmares and the other because the mother was unable to get her child to take the medication. Two mothers of children who completed the study lost or did not complete the diaries during the placebo period and their data were excluded from the diary analyses. The reasons why the other 39 children were not included in the study are given in Table 1 .
For the 18 children who completed the study the mean age at the time of referral was 21-9 months, with a range of 7 to 37 months. Eight were boys and 10 girls. Four were only children, two were first born, and 12 were later born, indicating that first born children did not seem to be over represented in our sample. All social classes were represented.
By maternal history, the wakeful children divided into two groups of nine children each. The first group had never settled at night and showed sleeping difficulties from birth and the second group seemed to sleep normally at birth, settling during the first few months, and developing night waking at a later date, often in conjunction with a minor physical illness such as otitis media. Many had received previous treatment with hypnotics with varying success.
Assessment of antenatal and perinatal adversity was based on maternal report alone; several mothers had required admissions to hospital for hypertension during the third trimester, two with subsequent induction of labour. One delivery was by caesarean section after prolonged labour. According to the history given by the mother, no child was Children's behaviour was rated for disturbance in five areas. Table 2 shows that the areas of disobedience/defiance and temper tantrums showed the greater number of moderate or severe problems. Although there was considerable variability in the number and severity of behaviour problems displayed by individual children, no child was without behaviour problems in spheres other than sleep but only one child showed two 'severe' problems.
Characteristics of the parents. By means of a standardised interview of the mothers, both parents were rated for past and present psychiatric history, with the threshold for disorder being consultation with the general practitioner or a psychiatrist. Eight mothers and five fathers had a past psychiatric problem. In the mothers the history was of depression in all cases, while in the fathers the history was divided between depression (three cases) and physical symptoms diagnosed as 'psychosomatic' (two).
Currently, six of the mothers rated themselves as depressed, although only one had consulted her general practitioner. Three of the fathers were currently suffering with psychosomatic symptoms and one had recently made a suicide attempt.
Sleep diaries. Comparison of the mothers' descriptions of their children's sleep at initial interviews with baseline sleep diaries revealed a significant overestimation of the number of night wakings, with a non-significant trend to overestimate the time awake at night and to underestimate the total time asleep at the interview (Table 3) . Many mothers seemed to be aware of the discrepancy, commenting after the baseline period that their children seemed to have slept better in the past two weeks.
Baseline measures for the group receiving drug first were compared with those of the group receiv- ing placebo first to ensure their initial similarity. There were no significant differences between the two groups except on daytime sleep. This difference could not be explained by the age of the children and became non-significant when data on the two children whose placebo diaries were missing were added. Sleep variables during treatment with drug and placebo were compared using the method described by Armitage (Table 4) . While on trimeprazine, children slept longer at night, had fewer night wakings, and spent less time awake at night. No significant differences in daytime sleep were found. There were no significant period effects or treatment period interactions for any of the sleep variables, indicating that the effects of trimeprazine and placebo were independent of the order in which they were given.
Comparisons of all sleep variables in the first and fourth week of treatment with drug were made to assess whether trimeprazine retained its efficacy throughout the course of treatment. No significant differences in any sleep variables were seen.
Comparisons of the follow up diaries with baseline measures (Table 5) showed an overall improvement in sleep, with significantly fewer night time wakings and less time awake at night at follow up. As there was no period effect for the crossover, and hence no carryover effect from drug to placebo in the group given the drug first, the overall improvement at follow up was unlikely to be a direct effect of the drug.
Parent ratings. The weekly symptom checklists revealed that a number of parents reported their children to be eating and drinking more while on trimeprazine. Three children had a bout of diarrhoea while on placebo. In their overall treatment ratings parents thought trimeprazine was significantly better than placebo on all measures of sleep, The results of this study suggest that trimeprazine may be an effective treatment for reducing the number of night wakings and time awake during the night in young children. Furthermore, parents thought that trimeprazine was more helpful than placebo. This is in contrast to the more anecdotal reports from one survey that suggested that medication did not improve the sleep of many children treated.'3 One possible explanation for this difference is the fairly high doses of trimeprazine used in this study. It is noteworthy that no adverse effects were observed at this dose and that the often cited side effects of daytime sleepiness and irritability almost always ceased after several days of treatment with the drug.
These results are roughly comparable with those reported by Richman'7 but, because the data are described in a somewhat different manner, direct comparisons are not possible. There is some indication that the children in our study had more night wakings on placebo, suggesting a more severe problem. Thus the fact that night wakings were reduced on average 40% (mean 2-4 wakings a night on placebo reduced to mean 1*4 wakings a night on medication) in our study compared with roughly 25% on average in Richman's report may reflect the greater initial severity of the problem in our sample, the effect of a higher drug dose, or some other factor or combination of factors.
The immediate effect of trimeprazine in reducing night wakings and the continued efficacy over four weeks are of clinical importance in considering this form of treatment for the sleepless child. The 
